CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 35 enrolled
Drug / intervention
Experimental Group 1: Color Correcting Lenses +4 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05463016
NCT05463016N/ACompleted
CompareCT.gov

Immediate and Extended Wear Impact of Color Correcting Lenses on Color Vision Deficiency

University of the Incarnate Word·interventional·Posted Jul 18, 2022·Updated Apr 3, 2024

In Brief

A clinical study evaluating Experimental Group 1: Color Correcting Lenses, Placebo Group 1: Placebo Lenses, and 3 other interventions for Color Blindness and 3 related conditions. Completed, enrolled 35 participants across 1 site.

Detailed Summary

To demonstrate improved color vision in subjects with color vision deficiencies while wearing color-correcting lenses and after color-correcting lense use.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColor Blindness, Color Vision Defects, Color Blindness, Green, Color Blindness, Red
CountriesUnited States
CollaboratorsNational Eye Institute (NEI)

Timeline

N/ACompletedFinished
2023202420252026
First PostedJul 18, 2022
Enrollment StartJul 28, 2022
Primary CompletionAug 1, 2023
Study CompletionMar 31, 2024
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 4.0 years ago

Interventions

Experimental Group 1: Color Correcting Lensesdevice

Color Correcting Lenses

Placebo Group 1: Placebo Lensesdevice

Placebo Lenses

Placebo Group 1 Crosses over to become Experimental Group 2: Color Correcting Lensesdevice

Color Correcting Lenses

Experimental Group 1 Crosses over to become Placebo Group 2: Placebo Lensesdevice

Placebo Lenses

Color Correcting Lenses in Subjects with Normal Color Visiondevice

Color Correcting Lenses